IMUN
Immune Therapeutics Inc

260
Loading...
Loading...
Biostax Corp. engages in the acquisition, development, and commercialization of pharmaceutical and biotechnology products. Its partnered programs include JKB-122, Londonal, and Low Dose Naltrexone. The company was founded by Noreen Griffin on December 2, 1993 and is headquartered in Winter Park, FL.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Immune Therapeutics Inc?
What is the 52-week high for Immune Therapeutics Inc?
What is the 52-week low for Immune Therapeutics Inc?
What is Immune Therapeutics Inc stock price today?
What was Immune Therapeutics Inc stock price yesterday?
What is the PE ratio of Immune Therapeutics Inc?
What is the Price-to-Book ratio of Immune Therapeutics Inc?
What is the 50-day moving average of Immune Therapeutics Inc?

Latest IMUN News

View
No IMUN news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.